BROMAX SUMMARY
Bromax Tablet contains Brompheniramine Maleate, an antihistamine.
Bromax (Brompheniramine Maleate) is indicated for the temporary relief of symptoms associated with seasonal and perennial allergic rhinitis and vasomotor rhinitis.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Bromax (Brompheniramine)
Immunotherapy Effective in Pediatric Asthma and Rhinitis
Source: Medscape Allergy & Clinical Immunology Headlines [2013.05.13]
Subcutaneous and sublingual immunotherapy are both helpful for kids with asthma and rhinitis - and the sublingual approach has some advantages, although it doesn't have regulatory approval.
Reuters Health Information
Review Article Examines Sublingual Immunotherapy For Treatment Of Allergic Rhinitis And Asthma
Source: Allergy News From Medical News Today [2013.03.28]
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA...
Chronic Rhinitis and Post-Nasal Drip
Source: MedicineNet Rhinoplasty Specialty [2008.07.21]
Title: Chronic Rhinitis and Post-Nasal Drip
Category: Diseases and Conditions
Created: 7/13/1998 12:00:00 AM
Last Editorial Review: 7/21/2008 12:00:00 AM
News From The Annals Of Internal Medicine: Feb. 19, 2013
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2013.02.20]
1. Acupuncture May be an Effective Alternative for Treating Seasonal Allergies Patients receiving acupuncture treatments for seasonal allergic rhinitis reported statistically significant improvements in symptoms and decreased use of medication compared to patients having standard treatment or sham acupuncture, but the clinical significance of the observed improvements is uncertain...
Clinical Trials Related to Bromax (Brompheniramine)
Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis [Not yet recruiting]
This is a multicenter clinical trial, phase III, non-inferiority, controlled by active
medicine, open, randomized, enroll 538 children, 2 to 12 years old, with acute inflammation
upper airway, characterized by nasal congestion and runny nose, lasting at least 24 hours
and a maximum of 48 hours prior to inclusion. The subjects will be allocated in 2 parallel
groups, and will receive the medicines of study, according of the randomization.
Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis [Not yet recruiting]
Multicenter clinical trial, phase III, controlled by active medicine, open, randomized,
enroll 962 children, 2 to 12 years old, that suffer acute inflammation upper airway
characterized by non-productive cough, daytime/nighttime, with duration for at least 3 and
no more than 5 consecutive days (without systemic/topic use of medication during this
period) followed by nasal congestion, with or without associate other nasal symptoms
(sneezing, runny nose, nasal itching and/or mouth breathing). The subjects will be allocated
in 2 parallel groups, and will receive the medicines of study, according of the
randomization.
Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis [Not yet recruiting]
This is a multicenter clinical trial, phase III, superiority, controlled by active medicine,
double-blind, randomized, enroll 166 children, over 12 years old, with acute inflammation
upper airway, characterized by nasal congestion and runny nose, lasting at least 24 hours
and a maximum of 48 hours prior to inclusion. The subjects will be allocated in 2 parallel
groups, and will receive the medicines of study, according of the randomization.
|
|
|
|
Page last updated: 2013-05-13
|
